Healio/Orthopedics Today—August 12, 2016
Healio reports that pSivida Corp and Hospital for Special Surgery have announced its initiation of an investigational new drug application to begin a study of the sustained-released implant to treat severe knee osteoarthritis.
The article states that, "The device is designed to provide long-term pain relief for patients with severe knee osteoarthritis and will be implanted into the non-articulating part of the knee during an outpatient procedure."
Robert N. Hotchkiss, MD, a hand and upper extremity surgeon at Hospital for Special Surgery, says, "We believe this product has the potential to provide long-term pain relief and to contribute to improved joint function for patients with severe osteoarthritis, which can delay knee replacement surgery."
To read the full article, visit Healio.com.